|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/20/20 Uppercut Brands, Inc. 10-K 12/31/19 73:18M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 518K
2: EX-3.9 Certificate of Designation of the Series B HTML 28K
Convertible Preferred Stock
3: EX-10.7 Form of Securities Purchase Agreement for the HTML 245K
Purchase of Series B Preferred Shares, Dated
November 2019, Between Uppercut Brands, Inc., and
Investors
4: EX-10.8 Form of Warrant Related to Series B Preferred HTML 108K
Shares, Dated November 2019, Between Uppercut
Brands, Inc., and Investors
5: EX-10.9 Form of Registration Rights Agreement Related to HTML 131K
Series B Preferred Shares, Dated November 2019,
Between Uppercut Brands, Inc., and Investors
6: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 28K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 22K
30: R1 Document and Entity Information HTML 60K
67: R2 Balance Sheets HTML 94K
45: R3 Balance Sheets (Parenthetical) HTML 62K
23: R4 Statements of Operations HTML 80K
32: R5 Statements of Changes in Stockholders' Equity HTML 79K
(Deficit)
69: R6 Statements of Cash Flows HTML 113K
47: R7 Organization and Business HTML 29K
26: R8 Summary of Significant Accounting Policies HTML 63K
29: R9 Acquisition HTML 32K
19: R10 Fair Value of Financial Instruments And Fair Value HTML 47K
Measurements
41: R11 Inventory HTML 26K
60: R12 Notes Receivable HTML 31K
53: R13 Intangible Assets HTML 28K
18: R14 Convertible Notes Payable HTML 35K
40: R15 Note Payable - Related Party HTML 24K
59: R16 Stockholders? Equity (Deficit) HTML 66K
52: R17 Income Taxes HTML 42K
20: R18 Concentrations HTML 25K
39: R19 Subsequent Events HTML 24K
73: R20 Summary of Significant Accounting Policies HTML 118K
(Policies)
50: R21 Summary of Significant Accounting Policies HTML 26K
(Tables)
28: R22 Acquisition (Tables) HTML 25K
36: R23 Fair Value of Financial Instruments and Fair Value HTML 45K
Measurements (Tables)
72: R24 Inventory (Tables) HTML 25K
49: R25 Notes Receivable (Tables) HTML 26K
27: R26 Intangible Assets (Tables) HTML 25K
34: R27 Convertible Notes Payable (Tables) HTML 29K
71: R28 Stockholders? Equity (Deficit) (Tables) HTML 42K
51: R29 Income Taxes (Tables) HTML 35K
55: R30 Organization and Business (Details) HTML 25K
61: R31 Summary of Significant Accounting Policies HTML 30K
(Details)
37: R32 Summary of Significant Accounting Policies HTML 47K
(Details Textual)
16: R33 Acquisition (Details) HTML 31K
56: R34 Acquisition (Details Textual) HTML 50K
62: R35 Fair Value of Financial Instruments and Fair Value HTML 27K
Measurements (Details)
38: R36 Fair Value of Financial Instruments and Fair Value HTML 30K
Measurements (Details 1)
17: R37 Fair Value of Financial Instruments and Fair Value HTML 26K
Measurements (Details 2)
54: R38 Fair Value of Financial Instruments and Fair Value HTML 27K
Measurements (Details 3)
63: R39 Fair Value of Financial Instruments and Fair Value HTML 23K
Measurements (Details Textual)
44: R40 Inventory (Details) HTML 28K
66: R41 Notes Receivable (Details) HTML 29K
31: R42 Notes Receivable (Details Textual) HTML 58K
22: R43 Intangible Assets (Details) HTML 24K
46: R44 Intangible Assets (Details Textual) HTML 35K
68: R45 Convertible Notes Payable (Details) HTML 32K
33: R46 Convertible Notes Payable (Details 1) HTML 28K
25: R47 Convertible Notes Payable (Details Textual) HTML 53K
43: R48 Note Payable - Related Party (Details) HTML 33K
70: R49 Stockholders? Equity (Deficit) (Details) HTML 66K
65: R50 Stockholders? Equity (Deficit) (Details Textual) HTML 152K
58: R51 Income Taxes (Details) HTML 39K
21: R52 Income Taxes (Details 1) HTML 34K
42: R53 Income Taxes (Details Textual) HTML 28K
64: R54 Concentrations (Details) HTML 24K
57: R55 Subsequent Events (Details) HTML 28K
35: XML IDEA XML File -- Filing Summary XML 124K
48: EXCEL IDEA Workbook of Financial Reports XLSX 74K
10: EX-101.INS XBRL Instance -- ucut-20191231 XML 722K
12: EX-101.CAL XBRL Calculations -- ucut-20191231_cal XML 134K
13: EX-101.DEF XBRL Definitions -- ucut-20191231_def XML 432K
14: EX-101.LAB XBRL Labels -- ucut-20191231_lab XML 799K
15: EX-101.PRE XBRL Presentations -- ucut-20191231_pre XML 639K
11: EX-101.SCH XBRL Schema -- ucut-20191231 XSD 149K
24: ZIP XBRL Zipped Folder -- 0001213900-20-007000-xbrl Zip 105K
Exhibit 3.9
C:
C:
C:
C:
C:
C:
C:
C:
C:
C:
C:
C:
C:
C:
C:
C:
C:
C:
C:
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/25/24 Silo Pharma, Inc. 10-K 12/31/23 69:6.7M EdgarAgents LLC/FA 3/24/23 Silo Pharma, Inc. 10-K 12/31/22 65:6.8M EdgarAgents LLC/FA 9/20/22 Silo Pharma, Inc. S-1/A 78:9.4M EdgarAgents LLC/FA 9/09/22 Silo Pharma, Inc. S-1/A 9/08/22 80:9.6M EdgarAgents LLC/FA 8/29/22 Silo Pharma, Inc. S-1/A 8/26/22 79:9.5M EdgarAgents LLC/FA 7/25/22 Silo Pharma, Inc. S-1/A 7/22/22 78:9.9M EdgarAgents LLC/FA 3/28/22 Silo Pharma, Inc. 10-K 12/31/21 69:6.2M EdgarAgents LLC/FA 12/07/21 Silo Pharma, Inc. S-1 12/08/21 88:9.2M EdgarAgents LLC/FA 5/17/21 Silo Pharma, Inc. 10-K/A 12/31/20 69:4.5M EdgarAgents LLC/FA 4/07/21 Silo Pharma, Inc. S-1/A 65:4.4M EdgarAgents LLC/FA 3/29/21 Silo Pharma, Inc. 10-K 12/31/20 69:4.5M EdgarAgents LLC/FA 2/16/21 Silo Pharma, Inc. S-1 73:5.5M EdgarAgents LLC/FA |